First Commercially Sponsored Clinical Trial in Regional Western Australia Targets Chemotherapy-Induced Nausea
核心洞察
Eli Lilly and Company sponsors the first commercially backed clinical trial in regional Western Australia through the WA Country Health Service Trial Centre.
The Phase 2, double-blind, placebo-controlled YAAD trial evaluates a new medicine for chemotherapy-induced nausea and vomiting (搜索).
Dedicated laboratory spaces at Albany and Esperance Health Campuses enable local sample collection and participant monitoring.
Western Australia has reached a significant milestone in decentralizing clinical research with the launch of the first commercially sponsored clinical trial in regional WA. The study, sponsored by international oncology research company Eli Lilly and Company, is being delivered through the WA Country Health Service (WACHS) Trial Centre in collaboration with clinicians in the Goldfields and Great Southern regions.
The YAAD clinical trial is a Phase 2, double-blind, placebo-controlled study evaluating the efficacy of a new medicine to treat chemotherapy-induced nausea and vomiting (搜索). Participants are randomly assigned into two groups: one receives the investigational medicine and the other receives a placebo. Both groups then proceed with their planned chemotherapy treatment and receive usual standard-of-care antiemetic medicine.
Building Regional Research Infrastructure
To support the trial, dedicated in-house laboratory spaces have been established at the Albany and Esperance Health Campuses. These facilities enable the collection of local samples while regional clinicians administer medication and monitor participant health. The infrastructure investment reflects a broader strategy to build sustainable clinical trial capacity outside metropolitan centers.
Medical Research Minister Stephen Dawson emphasized the significance of the initiative. "This trial marks a major milestone in building WA's clinical trial reputation globally, by attracting world-class treatments, industry research collaborations, and long-term investment into country communities," he said. "Thanks to this work, patients are able to access a cutting-edge trial without having to travel to the metropolitan area."
Advancing Healthcare Equity
The trial addresses a persistent gap in healthcare access for rural and remote populations. "Ensuring rural and remote communities have access to trials like this one is crucial to improving equity in health care," Minister Dawson stated, adding that the Cook Labor Government's investment in regional clinical trial capability is improving patient outcomes while positioning Western Australia as a key player on the national and global research stage.
Health Minister Meredith Hammat reinforced this perspective. "We are building a strong and sustainable clinical trials network that is ensuring country patients can access world-class research and healthcare closer to home," she said. "No matter where Western Australians live, they should have the opportunity to benefit from the latest medical advances, and having country hospitals involved in clinical trials is helping make that a reality."
Future Outlook
The successful launch of this commercially sponsored trial signals growing confidence in regional health services' ability to conduct rigorous clinical research. Minister Hammat noted that the trial "highlights the growing capability of our regional health services and gives me great confidence that more country patients will be able to access innovative treatments and research opportunities in the future."